title: Linear IgA Bullous Dermatosis Associated with Immunoglobulin Light-chain Amyloidosis.
authors.affiliation: Department of Dermatology, Hokkaido University Graduate School of Medicine, , Japan.
authors.forename: Yasuyuki
authors.initials: Y
authors.lastname: Yamaguchi
authors.forename: Hideyuki
authors.initials: H
authors.lastname: Ujiie
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Ohigashi
authors.forename: Hiroyuki
authors.initials: H
authors.lastname: Iwata
authors.forename: Ken
authors.initials: K
authors.lastname: Muramatsu
authors.forename: Tomoyuki
authors.initials: T
authors.lastname: Endou
authors.forename: Takanori
authors.initials: T
authors.lastname: Teshima
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Shimizu
mesh_terms: D000368:Aged; D000686:Amyloidosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D001323:Autoantibodies / Q000276:immunology*; D001706:Biopsy; D004359:Drug Therapy, Combination; D005455:Fluorescent Antibody Technique; D005938:Glucocorticoids / Q000627:therapeutic use; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D007147:Immunoglobulin Light Chains / Q000276:immunology*; D062027:Linear IgA Bullous Dermatosis / Q000175:diagnosis / Q000188:drug therapy / Q000276:immunology*; D008297:Male; D061988:Proteasome Inhibitors / Q000627:therapeutic use; D012867:Skin / Q000187:drug effects / Q000276:immunology* / Q000473:pathology; D016896:Treatment Outcome
chemical_list: D001323:Autoantibodies; D005938:Glucocorticoids; D007070:Immunoglobulin A; D007147:Immunoglobulin Light Chains; D061988:Proteasome Inhibitors